12:00 AM
 | 
Jan 16, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Therapeutic HCV vaccine: Phase I data

The open-label Phase I HCV001 trial in about 40 healthy volunteers showed that Okairos' therapeutic HCV vaccine was safe and well tolerated. Both vectors contained in the vaccine primed...

Read the full 125 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >